John B. Bode - 24 Mar 2026 Form 4 Insider Report for ZEVRA THERAPEUTICS, INC. (ZVRA)

Reporting relationship: Director
Issuer ticker: ZVRA
Reported as of: 24 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 Mar 2026, 08:27:07 UTC
Prior SEC filing: 03 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Timothy J. Sangiovanni, Attorney-in-Fact for John B. Bode

Key filing fact

John B. Bode filed Form 4 for ZEVRA THERAPEUTICS, INC. (ZVRA) on 26 Mar 2026.

Key facts

This page summarizes John B. Bode's Form 4 filing for ZEVRA THERAPEUTICS, INC. (ZVRA).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 26 Mar 2026, 08:27.

Change

Previous filing in this sequence was filed on 03 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001612084 Primary reporting owner

Bode John B

Relationship: Director
Address: C/O ZEVRA THERAPEUTICS, INC., 101 FEDERAL STREET, BOSTON
Signature: /s/ Timothy J. Sangiovanni, Attorney-in-Fact for John B. Bode
Signature date: 26 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ZVRA transaction

Common Stock

Options Exercise

Transaction value
Shares: +39,200
Change %: +87%
Price: $4.97^*
Shares after: 84,200
Date: 24 Mar 2026
Ownership: Direct

ZVRA transaction

Common Stock

Options Exercise

Transaction value
Shares: +39,200
Change %: +47%
Price: $4.89^*
Shares after: 123,400
Date: 24 Mar 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ZVRA transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -39,200
Change %: -67%
Price: $0.000000^*
Shares after: 19,600
Date: 24 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 39,200
Exercise price: $4.97
Footnotes: F1

ZVRA transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -39,200
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 24 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 39,200
Exercise price: $4.89
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The remaining shares underlying this option, which was granted on May 3, 2023, will vest one day prior to the date of the third annual meeting of the Issuer's stockholders following the day of the grant, subject to the Reporting Person's continued service as a director.

Footnote F2

The shares underlying this option, which was granted on May 13, 2024, were fully vested.